Chinese Biotech Firm Duoning Biotechnology Closes Nearly $15M Series A+ Round

Login to View

Duoning Biotechnology, a Chinese biotech firm that focuses on providing serum-free cell culture medium, has raised nearly RMB100 million (US$14.88 million) in a series A+ round of financing, according to a statement released on Thursday.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Read 2 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription!

Enjoy comprehensive and exclusive data you can't find elsewhere!

More Info


Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in

China Money Network Subscription

RELATED NEWS